• Therapeutic Cataract & Refractive
  • Lens Technology
  • Glasses
  • Ptosis
  • AMD
  • COVID-19
  • DME
  • Ocular Surface Disease
  • Optic Relief
  • Geographic Atrophy
  • Cornea
  • Conjunctivitis
  • Myopia
  • Presbyopia
  • Allergy
  • Nutrition
  • Pediatrics
  • Retina
  • Cataract
  • Contact Lenses
  • Lid and Lash
  • Dry Eye
  • Glaucoma
  • Refractive Surgery
  • Comanagement
  • Blepharitis
  • OCT
  • Patient Care
  • Diabetic Eye Disease
  • Technology

Ophthonix strengthens lenses with improved AR coating


Ophthonix recently upgraded its lens portfolio with a cutting-edge anti-reflective (AR) coating, called ViZera

Vista, CA-Ophthonix recently upgraded its lens portfolio with a cutting-edge anti-reflective (AR) coating, called ViZera.

The new coating provides the same high level of clarity and glare reduction as the company’s previous AR coating, but with a higher Bayer value and enhanced abrasion-resistance, the company announced.

Eyeglass lenses are susceptible to both glare and scratches during normal usage. The ViZera AR coating increases clarity and longevity to help a patient's lenses cope with the hectic impact of daily life, the company said.

More information can be found at www.izonlens.com.

For more articles in this issue of InDispensable, click here.

Related Videos
Andy Morgenstern, OD, FAAO, FNAP chats with Optometry Times
R Tracy Williams, OD, FAAO with Optometry Times
Shan Lin, MD, speaks on Glaucoma 360 presentation in an interview with Ophthalmology Times
Cecelia Koetting, OD, FAAO, DIPABO, left, speaks with Optometry Times about the 2024 EnVision Summit
Bonnie An Henderson, MD, highlights key takeaways of the 2024 EnVision Summit, including diversity and family inclusion
Danica Marrelli, OD, FAAO, AAO Dipl, co-chair of EnVision Summit chats about geographic atrophy and glaucoma panels
Robert Weiss, former CEO and President of The Cooper Companies, Inc. (left) and Optometry Times' Assistant Managing Editor Emily Kaiser Maharjan Image Credit ©Optometry Times
© 2024 MJH Life Sciences

All rights reserved.